financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Lululemon Athletica Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Lululemon Athletica Inc.
Jun 6, 2024 5:09 AM

07:55 AM EDT, 06/06/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month price target by $115 to $435, 30.0x our FY 25 (Jan.) EPS estimate and below the company's 5-year average forward P/E multiple of 42.2x. We maintain our FY 25 EPS estimate of $14.50 and initiate our FY 26 EPS estimate at $17.00. LULU posts normalized Q1 EPS of $2.54 vs. $2.28, $0.14 above consensus estimates on revenues of $2.21B vs. $2.00B and $12M above estimates. By region in Q1, Americas revenue increased 3% Y/Y and International revenue increased 35%. Q1 adjusted gross margin expanded 20 bps to 57.7%. LULU raised its full-year EPS guidance to a range of $14.27 to $14.47 and also raised its share buyback program by $1B and now has $1.7B remaining. Although the company is experiencing growth deceleration in the Americas, we continue to believe LULU is the top player in apparel retail and expect a reacceleration in growth across the Americas and continued success in China (+45% in Q1) and internationally. Comp sales across its international segment increased 25% Y/Y in Q1.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Sell Opinion On Shares Of Illinois Tool Works Inc.
Research Alert: CFRA Keeps Sell Opinion On Shares Of Illinois Tool Works Inc.
Jul 31, 2025
01:50 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $225 (from $220) following ITW's Q2 print, valuing shares at 20x our 2026 EPS estimate of $11.25 (up from $11.02; 2025 EPS outlook raised...
Research Alert: CFRA Keeps Buy Opinion On Adss Of Sanofi
Research Alert: CFRA Keeps Buy Opinion On Adss Of Sanofi
Jul 31, 2025
01:35 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target price to USD57 from USD65, which implies a 2025 P/E of 12.8x. This is in line with peer average and above its five-year historical forward P/E...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Ing Group
Research Alert: CFRA Keeps Hold Opinion On Adss Of Ing Group
Jul 31, 2025
12:50 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to USD25 from USD22, reflecting consensus 2025 P/B of 1.31x. The implied premium to its five-year historical average P/B of 0.84x is justified in...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk
Aug 1, 2025
07:05 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price to USD40 (USD43), implying 9x our 2025 EPADS estimate, implying a 2025 P/E of 9x, which is largely in line with its three-year historical forward...
Copyright 2023-2026 - www.financetom.com All Rights Reserved